Shares of iRhythm Technologies fell 2.8% in afternoon trading after Truist cut its price target on the stock to $18 from $160, overshadowing the company's strong second-quarter earnings report. Despite beating earnings estimates and raising full-year revenue guidance, investor focus turned to the drastic reduction, which likely signaled concern even though Truist maintained a Buy rating. The stock later pared losses to trade at $125.41, down 1.9% from the previous close. iRhythm is down 28.4% since the beginning of the year and trading 33.7% below its 52-week high of $189.25 from January 2026.
iRhythm Technologies IncTruist slashed price target to $18 from $160, overshadowing strong Q2 earnings and guidance raise.
